Read + Share
Ngo HX, Xu AY, Velasquez GE, Zhang N, et al. Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support
Flat-Dosing of Rifampicin for Tuberculosis. Clin Infect Dis 2024 Mar 11:ciae119. doi: 10.1093.
PMID: 38462673
|
 |
|
Ngo HX, Xu AY, Velasquez GE, Zhang N, et al. Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support
Flat-Dosing of Rifampicin for Tuberculosis. Clin Infect Dis 2024 Mar 11:ciae119. doi: 10.1093.
PMID: 38462673
|
|
|
|